Home

PRODUCT PIPELINE

Amarin's development pipeline includes a program in Huntington's disease and Myasthenia Gravis, two programs in Parkinson's disease, one in epilepsy, one in memory and a series of programs in cardiovascular disease.

VIEW OUR PIPELINE

View our Pipeline

LATEST NEWS

14-May-2008
Amarin announces private placement for up to $60 million
Full Story
More News »